FDA-Drug2024-05-29Class II
Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Preferred Pharmaceuticals, Inc.
Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Sold states
Product distributed to CA, FL, OK, KS and CT
Affected count
66 bottles of 30 tablets
Manufactured in
1250 N Lakeview Ave Ste O, Anaheim, CA, United States
Products
Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0505-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief